-transparent.png){kind=logo}
Patients frequently complain about changes in their everyday life after radical cystectomy and urinary diversion. The aim of this study was to compare subjective morbidity of ileal neobladder to the urethra versus ileal conduit urinary diversion and to elucidate its influence on quality of life. A total of 102 patients who underwent radical cystectomy due to a bladder malignancy were included in the study: 69 patients (67.6%) with an orthotopic neobladder and 33 patients (32.4%) with an ileal conduit. The compliance was 99% and mean follow-up was 37 months. All patients completed two retrospective quality-of-life questionnaires, namely the QLQ-C30 and a questionnaire developed at our institution to elucidate specific items regarding urinary diversion. The questioning was performed by a nonurologist. The results obtained from the validated (QLQ-C30) and our self-designed questionnaire clearly demonstrate that patients with an orthotopic neobladder better adapt to the new situation than patients with an ileal conduit. In addition, neobladder to the urethra improves quality of life due to a better self-confidence, better rehabilitation as well as restoration of leisure, professional, traveling, and social activities, and reduced risk of inadvertent loss of urine. For example, 74.6% of neobladder patients felt absolutely safe with the urinary diversion in contrast to 33.3% in the ileal conduit group. Only 1.5% of neobladder patients had wet clothes caused by urine leakage during day versus 48.5% of ileal conduit patients; 92.8% of neobladder patients felt not handicapped at all; and 87% felt not sickly or ill in contrast to 51.5% and 66.7% of ileal conduit patients, respectively. Moreover, 97% of our neobladder patients would recommend the same urinary diversion to a friend suffering from the same disease in contrast to only 36% of ileal conduit patients. The results obtained by this study demonstrate that quality of life is preserved in a higher degree after orthotopic neobladder than after ileal conduit urinary diversion.
A Hobisch, and
K Tosun, and
J Kinzl, and
G Kemmler, and
G Bartsch, and
L Höltl, and
A Stenzl
October 2009,
Annals of the Royal College of Surgeons of England,
A Hobisch, and
K Tosun, and
J Kinzl, and
G Kemmler, and
G Bartsch, and
L Höltl, and
A Stenzl
March 2015,
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
A Hobisch, and
K Tosun, and
J Kinzl, and
G Kemmler, and
G Bartsch, and
L Höltl, and
A Stenzl
April 2023,
European urology open science,
A Hobisch, and
K Tosun, and
J Kinzl, and
G Kemmler, and
G Bartsch, and
L Höltl, and
A Stenzl
March 2003,
The Journal of urology,
A Hobisch, and
K Tosun, and
J Kinzl, and
G Kemmler, and
G Bartsch, and
L Höltl, and
A Stenzl
March 2016,
Urologic oncology,
A Hobisch, and
K Tosun, and
J Kinzl, and
G Kemmler, and
G Bartsch, and
L Höltl, and
A Stenzl
May 2014,
BJU international,
A Hobisch, and
K Tosun, and
J Kinzl, and
G Kemmler, and
G Bartsch, and
L Höltl, and
A Stenzl
September 2020,
BJUI compass,
A Hobisch, and
K Tosun, and
J Kinzl, and
G Kemmler, and
G Bartsch, and
L Höltl, and
A Stenzl
February 2019,
European urology,
A Hobisch, and
K Tosun, and
J Kinzl, and
G Kemmler, and
G Bartsch, and
L Höltl, and
A Stenzl
January 2012,
ISRN urology,
A Hobisch, and
K Tosun, and
J Kinzl, and
G Kemmler, and
G Bartsch, and
L Höltl, and
A Stenzl
December 2017,
The Journal of urology,
